Jennifer Frye
Overview
Explore the profile of Jennifer Frye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
263
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laforest R, Ghai A, Fraum T, Oyama R, Frye J, Kaemmerer H, et al.
J Nucl Med
. 2022 Aug;
64(2):320-328.
PMID: 36008121
There remains an unmet need for molecularly targeted imaging agents for multiple myeloma (MM). The integrin very late antigen 4 (VLA4), is differentially expressed in malignant MM cells and in...
2.
Laforest R, Dehdashti F, Liu Y, Frye J, Frye S, Luehmann H, et al.
Mol Imaging
. 2017 Oct;
16:1536012117733349.
PMID: 29037107
Purpose: PGN650 is a F(ab') antibody fragment that targets phosphatidylserine (PS), a marker normally absent that becomes exposed on tumor cells and tumor vasculature in response to oxidative stress and...
3.
Laforest R, Lapi S, Oyama R, Bose R, Tabchy A, Marquez-Nostra B, et al.
Mol Imaging Biol
. 2016 May;
18(6):952-959.
PMID: 27146421
Purpose: The purpose of the present study is to evaluate safety, human radiation dosimetry, and optimal imaging time of [Zr]trastuzumab in patients with HER2-positive breast cancer. Procedures: Twelve women with...
4.
Lockhart A, Liu Y, Dehdashti F, Laforest R, Picus J, Frye J, et al.
Mol Imaging Biol
. 2015 Nov;
18(3):446-53.
PMID: 26567113
Purpose: The purpose of this study was to evaluate the safety, dosimetry, and apparent receptor occupancy (RO) of [(64)Cu]DOTA-patritumab, a radiolabeled monoclonal antibody directed against HER3/ERBB3 in subjects with advanced...
5.
Eissenberg L, Rettig M, Ritchey J, Prior J, Schwarz S, Frye J, et al.
Mol Ther
. 2015 Mar;
23(6):1110-1122.
PMID: 25807290
Described herein is a first-in-man attempt to both genetically modify T cells with an imagable suicide gene and track these transduced donor T cells in allogeneic stem cell transplantation recipients...
6.
Vaidya M, Creach K, Frye J, Dehdashti F, Bradley J, El Naqa I
Radiother Oncol
. 2011 Nov;
102(2):239-45.
PMID: 22098794
Background And Purpose: Prediction of local failure in radiotherapy patients with non-small cell lung cancer (NSCLC) remains a challenging task. Recent evidence suggests that FDG-PET images can be used to...
7.
Morrison H, Frye J, Davis-Gorman G, Funk J, McDonagh P, Stahl G, et al.
Curr Neurovasc Res
. 2011 Jan;
8(1):52-63.
PMID: 21208161
After complement system (CS) activation, the sequential production of complement products increases cell injury and death through opsonophagocytosis, cytolysis, adaptive, and inflammatory cell responses. These responses potentiate cerebral ischemia-reperfusion (IR)...